RAYMOND A. BONNER heads the Firm’s Food, Drug and Medical Device Compliance and Enforcement practice. He is a member of the Firm’s Executive Committee. He concentrates his practice on representing life science companies in connection with government investigations, enforcement proceedings and litigation. These investigations and related enforcement matters involve a range of matters including clinical studies, marketing practices, pricing and reimbursement, product safety and reporting, good manufacturing practices (“GMP”), quality system regulation (“QSR”), and HACCP.
Mr. Bonner also conducts internal company reviews regarding the range of subjects referenced above. He regularly visits manufacturing sites throughout the world to provide regulatory and compliance support regarding GMP and QSR matters.
Mr. Bonner also represents companies in connection with Foreign Corrupt Practices Act investigations and compliance programs, trade secret issues, and commercial matters.
Mr. Bonner served as an Assistant U.S. Attorney in the District of Maryland for six years, where he prosecuted pharmaceutical application and GMP cases and litigated other FDA-related cases. Throughout his tenure as a prosecutor, he counseled FDA and its Special Prosecution Staff investigating the health care industry. Mr. Bonner is the recipient of FDA’s Harvey W. Wiley Medical and Commissioner’s special citation.
Mr. Bonner received his J.D. from New York University School of Law and a B.A., summa cum laude, from the University of Maryland and clerked for the Honorable Paul H. Roney of the Eleventh Circuit Court of Appeals.